Cardiovalve is a transfemoral mitral valve replacement system. It is currently under preclinical evaluation and is expected to begin clinical studies during 2014.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.